Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ALPMF - Astellas Pharma Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2022 Results - Earnings Call Transcript

ALPMF - Astellas Pharma Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2022 Results - Earnings Call Transcript

Astellas Pharma Inc
Astellas Pharma, Inc. (ALPMF) Q4 2022 Results Conference Call April 27, 2022 01:00 AM ET Company Participants Hiromitsu Ikeda - Corporate Head, Advocacy and Relations Kenji Yasukawa - President and CEO Bernie Zeiher - Chief Medical Officer Yukio Matsui - Chief Commercial Officer Minoru Kikuoka - CFO Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Kazuaki Hashiguchi - Daiwa Securities Shinichiro Muraoka - Morgan Stanley Securities Fumiyoshi Sakai - Credit Suisse Securities Motoya Kohtani - Nomura Securities Akinori Ueda - Goldman Sachs Securities Presentation Kenji Yasukawa Hello, everyone. I’m Kenji Yasukawa from Astellas Pharma, Inc. Thank you very much for joining our FY 2021 financial results announcement meeting out of your very busy schedule today. Page 2 is a cautionary statement regarding forward-looking information. I’m not going to read this. Page 3 is the agenda for today. From Page 4, I’d like to go into the main topics. First, I

For further details see:

Astellas Pharma, Inc. (ALPMF) CEO Kenji Yasukawa on Q4 2022 Results - Earnings Call Transcript
Stock Information
Company Name: Astellas Pharma Inc
Stock Symbol: ALPMF
Market: OTC
Menu
ALPMF ALPMF Quote ALPMF Short ALPMF News ALPMF Articles ALPMF Message Board
Get ALPMF Alerts

News, Short Squeeze, Breakout and More Instantly...